Birth defects increase the number of newborn deaths
Since the cancellation of the "Compulsory Marriage Examination" in 2003, the birth defect rate of newborns has more than doubled in ten years. According to the "Report on the Prevention and Treatment of Birth Defects in China (2012)", the total number of birth defects in China is about 900,000 per year Approximately 5.6% of the total number of people born each year. There are many factors leading to birth defects, of which genetic factors play an important role.
Birth defects are not a single disease. They refer to structural, functional, or metabolic abnormalities that occur before and after birth. These abnormalities include congenital heart disease, brainless children, thalassemia, Down syndrome, cartilage dysplasia, and phenylacetone. There are hundreds of types of urination and polydactyly. Faye Wong and Li Yanpeng's daughter Li Yan have received widespread attention because of their "congenital cleft lip and palate".
Severe adverse drug reactions in children
In addition to birth defects, the current status of adverse drug reactions in children is not optimistic. According to data from the Ministry of Health's Adverse Drug Reaction Testing Center, the adverse drug reaction rate for infants and young children in China is 12.9%, of which 24.4% are newborns, and 30,000 infants and young children are deaf every year due to improper medication. Because the genetic characteristics of the child determine the strength of the drug ’s metabolic capacity, the same drug is a good medicine for some children, but it may be a poison for other children, so the doctor will ask the child if he uses some drugs. There will be a history of allergies or do a drug test first.
Genetic testing brings direction to healthy parenting
Severe birth defects and the current situation of children's poor medications stimulate parents' sensitive and fragile nerves, and people's demand for new detection technologies to more easily protect their health is constantly increasing.
Among them, the first technology to enter the field of child care health is non-invasive DNA prenatal testing. It has the characteristics of non-invasive, early, comprehensive, high accuracy and sensitivity.
What is non-invasive DNA prenatal testing technology?
Non-invasive DNA prenatal detection technology only requires the use of pregnant women's venous blood, using next-generation DNA sequencing technology to sequence the free DNA fragments in the maternal peripheral plasma, and the sequencing results are analyzed for biological information to obtain the genetic information of the fetus for detection Whether the fetus has chromosomal diseases such as Down syndrome, Edwards syndrome, Patau syndrome, etc. These three major chromosomal abnormalities mainly represent mental retardation and abnormal growth and development. The mature performance of DNA sequencing technology ensures the accuracy of the technology, which can reach more than 99%. Pregnant women can usually be checked after more than 12 weeks of pregnancy.
Genetic testing can not only screen for genetic diseases, but also learn about the genetic pathogenic genes carried by the testers, and customize childcare guidance products for children with personalized health, growth, and safe medication. In addition, the use of big data technology can understand the genetic factors of children's health and development, provide targeted feeding, diet and health management programs. It is a good helper to control family risks and raise healthy children.
According to the statistics of the National Bureau of Statistics, the population born in mainland China in 2019 was 14.65 million, with a birth rate of 10.48%. Among the population born in 2019, the proportion of children with two or more children reached 59.5%. The second child ’s family is better in terms of economic ability. Parents who choose to have a second child are older. We know that the older the age, the more disadvantageous it is for the birth of a child. Hehe also gradually joined the army of vitality. The new generation of parents has a higher acceptance of new technologies and services. Therefore, the integration of genetic testing into maternal and child health will inject new vitality into the maternal and infant market.
From July 9th to 11th, Guangzhou Zhenghe Exhibition Service Co., Ltd. will host the 2020 Shanghai International Maternal and Infant Health Expo in Hall E4 of the Shanghai New International Expo Center. Nearly two hundred obstetrics and gynecology hospitals, IVF centers, maternal and child health institutions, confinement centers, postpartum repair centers and other institutions in the region will attend the exhibition and are committed to building a one-stop maternal and child health service platform. ) Mom groups and families come to visit.